These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32499782)

  • 1. TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy.
    Skeate JG; Otsmaa ME; Prins R; Fernandez DJ; Da Silva DM; Kast WM
    Front Immunol; 2020; 11():922. PubMed ID: 32499782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas.
    Han M; Sun Y; Zhao W; Xiang G; Wang X; Jiang Z; Xue Z; Zhou W
    Front Immunol; 2022; 13():1025286. PubMed ID: 36341396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.
    Johansson-Percival A; He B; Li ZJ; Kjellén A; Russell K; Li J; Larma I; Ganss R
    Nat Immunol; 2017 Nov; 18(11):1207-1217. PubMed ID: 28892469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
    Mooradian MJ; Sullivan RJ
    Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies.
    Galon J; Bruni D
    Nat Rev Drug Discov; 2019 Mar; 18(3):197-218. PubMed ID: 30610226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Opportunities and Challenges in Cancer Immunotherapy.
    Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
    Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumors with LIGHT to generate metastasis-clearing immunity.
    Yu P; Fu YX
    Cytokine Growth Factor Rev; 2008; 19(3-4):285-94. PubMed ID: 18508404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy.
    He B; Johansson-Percival A; Backhouse J; Li J; Lee GYF; Hamzah J; Ganss R
    Cell Rep; 2020 Jan; 30(3):714-724.e5. PubMed ID: 31968248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy.
    Andersson P; Ostheimer C
    Front Immunol; 2019; 10():2083. PubMed ID: 31555290
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis: Opening a new window for immunotherapy.
    Guo F; Cui J
    Life Sci; 2020 Oct; 258():118163. PubMed ID: 32738363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.
    Lin L; Hu X; Zhang H; Hu H
    Front Immunol; 2019; 10():1398. PubMed ID: 31281318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges.
    Duan J; Wang Y; Jiao S
    Cancer Med; 2018 Sep; 7(9):4517-4529. PubMed ID: 30088347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.
    Uher O; Caisova V; Hansen P; Kopecky J; Chmelar J; Zhuang Z; Zenka J; Pacak K
    Semin Oncol; 2019; 46(4-5):385-392. PubMed ID: 31739997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    Qiao G; Qin J; Kunda N; Calata JF; Mahmud DL; Gann P; Fu YX; Rosenberg SA; Prabhakar BS; Maker AV
    Cancer Res; 2017 Apr; 77(8):1880-1891. PubMed ID: 28249900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice.
    Jiang W; Chen R; Kong X; Long F; Shi Y
    Vaccine; 2014 Jul; 32(35):4565-4570. PubMed ID: 24951859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.